Changes in emotional behavior of mice in the hole-board test after olfactory bulbectomy

Journal of Pharmacological Sciences

Volumn 102, Issue 4, 2006, Pages 377-386

  Saitoh, Akiyoshi ^a   Hirose, Noritaka ^a   Yamada, Mitsuhiko ^b   Yamada, Misa ^b   Nozaki, Chihiro ^a   Oka, Takuma ^a   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Anxiolytic; Hole board test; Olfactory bulbectomy; Opioid receptor

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DIAZEPAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOSMIA; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EMOTIONALITY; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; MOUSE; NONHUMAN; OLFACTORY BULBECTOMY; SOCIAL ISOLATION;

EID: 33845620704     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0060837     Document Type: Article

References (39)

1. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci. 2002;23:238-245.
2. Cryan JF, Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry. 2004;9:326-357.
3. Harkin A, Kelly JP, Leonard BE. A review of the relevance and validity of olfactory bulbectomy as a model of depression. Clin Neurosci Res. 2003;3:253-262.
4. Kelly JP, Wrynn AS, Leonard BE. The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther. 1997;74:299-316.
5. Song C, Leonard BE. The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev. 2005;29:627-647.
6. Shibata S, Nakanishi H, Watanabe S, Ueki S. Effects of chronic administration of antidepressants on mouse-killing behavior (muricide) in olfactory bulbectomized rats. Pharmacol Biochem Behav. 1984;21:225-230.
7. Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Nakazato A, et al. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. J Pharmacol Exp Ther. 1999;289:926-935.
8. Chaki S, Nakazato A, Kennis L, Nakamura M, Mackie C, Sugiura M, et al. Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450. Eur J Pharmacol. 2004;485:145-158.
9. Slotnick BM, Jarvik ME. Deficits in passive avoidance and fear conditioning in mice with septal lesions. Science. 1966;154:1207-1208.
10. Otmakhova NA, Gurevich EV, Katkov YA, Nesterova IV, Bobkova NV. Dissociation of multiple behavioral effects between olfactory bulbectomized C57Bl/6J and DBA/2J mice. Physiol Behav. 1992;52:441-448.
11. Hozumi S, Nakagawasai O, Tan-No K, Niijima F, Yamadera F, Murata A, et al. Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy. Behav Brain Res. 2003;138:9-15.
12. Tadano T, Hozumi S, Yamadera F, Murata A, Niijima F, Tan-No K, et al. Effects of NMDA receptor-related agonists on learning and memory impairment in olfactory bulbectomized mice. Methods Find Exp Clin Pharmacol. 2004;26:93-97.
13. Bobkova NV, Nesterova IV, Nesterov VV. The state of cholinergic structures in forebrain of bulbectomized mice. Bull Exp Biol Med. 2001;131:427-431.
14. Zueger M, Urani A, Chourbaji S, Zacher C, Roche M, Harkin A, et al. Olfactory bulbectomy in mice induces alterations in exploratory behavior. Neurosci Lett. 2005;374:142-146.
15. Boissier JR, Simon P. [The exploration reaction in mouse.] Therapie. 1962;17:1225-1232. (in French)
16. Montgomery KC. The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol. 1955;48:254-260.
17. Takeda H, Tsuji M, Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur J Pharmacol. 1998;350:21-29.
18. Tsuji M, Takeda H, Matsumiya T. Different effects of 5-HT1A receptor agonists and benzodiazepine anxiolytics on the emotional state of naive and stressed mice: a study using the hole-board test. Psychopharmacology. 2000;152:157-166.
19. Kamei J, Ohsawa M, Tsuji M, Takeda H, Matsumiya T. Modification of the effects of benzodiazepines on the exploratory behaviors of mice on a hole-board by diabetes. Jpn J Pharmacol. 2001;86:47-54.
20. Kamei J, Matsunawa Y, Miyata S, Tanaka S, Saitoh A. Effects of nociceptin on the exploratory behavior of mice in the hole-board test. Eur J Pharmacol. 2004; 489:77-87.
21. File SE. What can be learned from the effects of benzodiazepines on exploratory behavior? Neurosci Biobehav Rev. 1985;9:45-54.
22. Lister RG. Interactions of Ro 15-4513 with diazepam, sodium pentobarbital and ethanol in a holeboard test. Pharmacol Biochem Behav. 1987;28:75-79.
23. Lister RG. The effects of ethanol on exploration in DBA/2 and C57Bl/6 mice. Alcohol. 1987;4:17-19.
24. Bilkei-Gorzo A, Gyertyan I. Some doubts about the basic concept of hole-board test. Neurobiology. 1996;4:405-415.
25. Hoshino K, Uga DA, de Paula HM. The compulsive-like aspect of the head dipping emission in rats with chronic electrolytic lesion in the area of the median raphe nucleus. Braz J Med Biol Res. 2004;37:245-250.
26. Tsuji M, Takeda H, Matsumiya T. Different effects of 5-HT1A receptor agonists and benzodiazepine anxiolytics on the emotional state of naive and stressed mice: a study using the hole-board test. Psychopharmacology. 2000;152:157-166.
27. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, et al. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet. 2000;25:195-200.
28. Konig M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, et al. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature. 1996;383:535-538.
29. Ragnauth A, Schuller A, Morgan M, Chan J, Ogawa S, Pintar J, et al. Female preproenkephalin-knockout mice display altered emotional responses. Proc Natl Acad Sci U S A. 2001;98:1958-1963.
30. Saitoh A, Yoshikawa Y, Onodera K, Kamei J. Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats. Psychopharmacology. 2005;182:327-334.
31. Holmes PV. Olfactory bulbectomy increases prepro-enkephalin mRNA levels in the ventral striatum in rats. Neuropeptides. 1999;33:206-211.
32. Primeaux SD, Holmes PV. Olfactory bulbectomy increases metenkephalin-and neuropeptide-Y-like immunoreactivity in rat limbic structures. Pharmacol Biochem Behav. 2000;67:331-337.
33. Saitoh A, Kimura Y, Suzuki T, Kawai K, Nagase H, Kamei J. Potential anxiolytic and antidepressant-like activities of SNC80, a selective δ-opioid agonist, in behavioral models in rodents. J Pharmacol Sci. 2004;95:374-380.
34. Crawley JN. Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev. 1985;9:37-44.
35. Weiss IC, Pryce CR, Jongen-Relo AL, Nanz-Bahr NI, Feldon J. Effect of social isolation on stress-related behavioural and neuroendocrine state in the rat. Behav Brain Res. 2004;152:279-295.
36. Mar A, Spreekmeester E, Rochford J. Antidepressants preferentially enhance habituation to novelty in the olfactory bulbectomized rat. Psychopharmacology. 2000;150:52-60.
37. Saitoh A, Yamada M, Yamada M, Kobayashi S, Hirose N, Honda K, et al. ROCK inhibition produces anxiety-related behaviors in mice. Psychopharmacology. 2006;188:1-11.
38. Murphy NP. Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems. Neuropsychopharmacology. 1990;3:457-471.
39. Harkin A, Kelly JP, McNamara M, Connor TJ, Dredge K, Redmond A, et al. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. Eur J Pharmacol. 1999;364:123-132.